| Database ID | Agent | Target | Cancer Type | Detail |
| DB01066 | sunitinib | FL cytokine receptor
Mast/stem cell growth factor receptor
Vascular endothelial growth factor receptor 2
Plateletderived growth factor receptor | breast cancer | view |
| DB01067 | sunitinib | FL cytokine receptor
Mast/stem cell growth factor receptor
Vascular endothelial growth factor receptor 2
Plateletderived growth factor receptor | breast cancer | view |
| DB01068 | sunitinib | FL cytokine receptor
Mast/stem cell growth factor receptor
Vascular endothelial growth factor receptor 2
Plateletderived growth factor receptor | breast cancer | view |
| DB01069 | sunitinib | FL cytokine receptor
Mast/stem cell growth factor receptor
Vascular endothelial growth factor receptor 2
Plateletderived growth factor receptor | breast cancer | view |
| DB01070 | Trastuzumab Emtansine | human epidermal growth factor receptor 2 and microtubuleinhibitory | breast cancer | view |
| DB01071 | Trastuzumab Emtansine | human epidermal growth factor receptor 2 and microtubuleinhibitory | breast cancer | view |
| DB01072 | Trastuzumab Emtansine | human epidermal growth factor receptor 2 and microtubuleinhibitory | breast cancer | view |
| DB01073 | Trastuzumab Emtansine | human epidermal growth factor receptor 2 and microtubuleinhibitory | breast cancer | view |
| DB01074 | trastuzumab | Receptor proteintyrosine kinase erbB2 | breast cancer | view |
| DB01075 | trastuzumab | Receptor proteintyrosine kinase erbB2 | breast cancer | view |
| DB01076 | trastuzumab | Receptor proteintyrosine kinase erbB2 | breast cancer | view |
| DB01077 | everolimus | Serine/threonineprotein kinase mTOR | breast cancer | view |
| DB01078 | everolimus | Serine/threonineprotein kinase mTOR | breast cancer | view |
| DB01079 | everolimus | Serine/threonineprotein kinase mTOR | breast cancer | view |
| DB01080 | palbociclib | Cell division protein kinase 6
Cell division protein kinase 4 | breast cancer | view |